{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:28:26Z","timestamp":1791178106608,"version":"4.1.0"},"reference-count":43,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The three skin disorders of Lyme borreliosis in Europe include erythema migrans, an acute, self-limited lesion; borrelial lymphocytoma, a subacute lesion; and acrodermatitis chronica atrophicans, a chronic lesion. Using quantitative reverse transcription-PCR, we determined mRNA expression of selected chemokines, cytokines, and leukocyte markers in skin samples from 100 patients with erythema migrans, borrelial lymphocytoma, or acrodermatitis chronica atrophicans and from 25 control subjects. Chemokine patterns in lesional skin in each of the three skin disorders included low but significant mRNA levels of the neutrophil chemoattractant CXCL1 and the dendritic cell chemoattractant CCL20 and intermediate levels of the macrophage chemoattractant CCL2. Erythema migrans and particularly acrodermatitis lesions had high mRNA expression of the T-cell-active chemokines CXCL9 and CXCL10 and low levels of the B-cell-active chemokine CXCL13, whereas lymphocytoma lesions had high levels of CXCL13 and lower levels of CXCL9 and CXCL10. This pattern of chemokine expression was consistent with leukocyte marker mRNA in lesional skin. Moreover, using immunohistologic methods, CD3<jats:sup>+<\/jats:sup>T cells and CXCL9 were visualized in erythema migrans and acrodermatitis lesions, and CD20<jats:sup>+<\/jats:sup>B cells and CXCL13 were seen in lymphocytoma lesions. Thus, erythema migrans and acrodermatitis chronica atrophicans have high levels of the T-cell-active chemokines CXCL9 and CXCL10, whereas borrelial lymphocytoma has high levels of the B-cell-active chemokine CXCL13.<\/jats:p>","DOI":"10.1128\/iai.00263-07","type":"journal-article","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T00:34:01Z","timestamp":1183422841000},"page":"4621-4628","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":71,"title":["Chemokine Signatures in the Skin Disorders of Lyme Borreliosis in Europe: Predominance of CXCL9 and CXCL10 in Erythema Migrans and Acrodermatitis and CXCL13 in Lymphocytoma"],"prefix":"10.1128","volume":"75","author":[{"given":"Robert R.","family":"Mu\u0308llegger","sequence":"first","affiliation":[{"name":"Department of Dermatology, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry K.","family":"Means","sequence":"additional","affiliation":[{"name":"Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junghee J.","family":"Shin","sequence":"additional","affiliation":[{"name":"Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Jones","sequence":"additional","affiliation":[{"name":"Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Glickstein","sequence":"additional","affiliation":[{"name":"Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Luster","sequence":"additional","affiliation":[{"name":"Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen C.","family":"Steere","sequence":"additional","affiliation":[{"name":"Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.3.1774-1780.2001"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-2508(94)90187-2"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1988.tb31833.x"},{"key":"e_1_3_2_5_2","first-page":"156","volume":"18","year":"1989","unstructured":"\u00c5sbrink, E., A. Hovmark, and I. Olsson. 1989. Lymphadenosis benigna cutis solitaria\u2014borrelia lymphocytoma in Sweden. Zentralbl. Bakteriol.18(Suppl):156-163.","journal-title":"Zentralbl. Bakteriol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1099\/00207713-42-3-378"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2002.tb00514.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/000155598441558"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.bmb.a072967"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.2.893"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.4.1217-1222.1997"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2003.00167.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0402455101"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.33.3.602-608.1995"},{"key":"e_1_3_2_15_2","first-page":"1","volume":"4","year":"2002","unstructured":"Douglas, M. R., K. E. Morrison, M. Salmon, and C. D. Buckley. 2002. Why does inflammation persist: a dominant role for the stromal microenvironment? Exp. Rev. Mol. Med.4:1-18.","journal-title":"Exp. Rev. Mol. Med."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.4049\/jimmunol.158.7.3285","volume":"158","year":"1997","unstructured":"Ebnet, K., K. D. Brown, U. K. Siebenlist, M. M. Simon, and S. Shaw. 1997. Borrelia burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J. Immunol.158:3285-3292.","journal-title":"J. Immunol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.3.1530-1536.2004"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1261"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-004-3110-4"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64981-4"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.11.6592"},{"key":"e_1_3_2_22_2","first-page":"1","volume":"105","year":"2002","unstructured":"Lebech, A. M. 2002. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification. APMIS Suppl.105:1-40.","journal-title":"APMIS Suppl."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2005.03.005"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.10.5165"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/340826"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00198.x"},{"key":"e_1_3_2_27_2","first-page":"296","volume":"14","year":"2004","unstructured":"M\u00fcllegger, R. R. 2004. Dermatological manifestations of Lyme borreliosis. Eur. J. Dermatol.14:296-309.","journal-title":"Eur. J. Dermatol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20486"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.2.403"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(01)00451-9"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00130.x"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.1.36-43.2002"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000171349.06645.79"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.5.2660"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.11311"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-6-200203190-00005"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.11.4384-4388.1997"},{"key":"e_1_3_2_38_2","first-page":"741","volume":"108","year":"1996","unstructured":"Stanek, G., S. O'Connell, M. Cimmino, E. Aberer, W. Kristoferitsch, M. Granstrom, E. Guy, and J. Gray. 1996. European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien. Klin. Wochenschr.108:741-747.","journal-title":"Wien. Klin. Wochenschr."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107123450207"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.4.708"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.3.768-776.1998"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1999.4022"},{"key":"e_1_3_2_43_2","first-page":"135","volume":"10","year":"2001","unstructured":"Weger, W., and R. R. M\u00fcllegger. 2001. Histopathology and immunohistochemistry of dermatoborreliosis. Acta Dermatoven. APA10:135-142.","journal-title":"Acta Dermatoven. APA"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1086\/382893"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.00263-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.00263-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T20:43:54Z","timestamp":1683924234000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.00263-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1128\/IAI.00263-07"],"URL":"https:\/\/doi.org\/10.1128\/iai.00263-07","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"2007-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-06-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}